Summit Therapeutics Inc. (SMMT) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 13.08B |
| Enterprise Value | 12.87B |
| P/E Ratio | -13.22 |
| PEG Ratio | 28.77 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 20 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -13.4 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.2 |
| Return On Equity | -1.39 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -1.08B |
| Net Income | -1.08B |
| Diluted EPS | -1.44 |
| Total Cash | 629.79M |
| Total Cash/Share | 0.79 |
| Total Debt | 19.98M |
| Total Debt/Equity | 0.04 |
| Current Ratio | 5.99 |
| Book Value Per Share | 0.71 |
| 52-Week Change | -21.52 |
| 52-Week High | 29.23 |
| 52-Week Low | 12.07 |
| Moving Average 50 Days | 16.41 |
| Moving Average 200 Days | 16.15 |
| Average Volume | 6.18M |
| Shares Outstanding | 797.75M |
| % Held by Institutions | 8.4 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |